Overview
The illicit drug market, particularly in Baltimore, exhibits characteristics of heightened potency and reduced cost for street drugs, a phenomenon noted five decades following the initiation of efforts aimed at making substance abuse prohibitively expensive. This development is observable through specific drug profiles and market dynamics.
Research Context
The context for this observation stems from a period beginning five decades prior, when a concerted effort, referred to as the “war on drugs,” was launched. The stated objective of this initiative was to render substance abuse unaffordable. However, contemporary observations suggest an outcome contrary to this original aim, with illicit drugs now being both cheaper and more powerful.
Approach
The insights presented are derived from an examination of the situation in Baltimore. This involved a direct visit to the city to observe and report on the prevailing conditions within its illicit drug market. The methodology is primarily observational and reportorial, focusing on specific examples of drug availability and characteristics within that geographical context.
Findings
- Increased Potency: Illicit street drugs are currently more powerful than in previous periods. This enhanced potency is a key characteristic of the contemporary drug supply.
- Decreased Cost: Concurrently with increased potency, illicit drugs are also cheaper. This affordability contributes to their widespread presence and use.
- Fentanyl's Role: Fentanyl is identified as a primary example of this trend, indicating its significant impact on the overall illicit drug supply. The presence and characteristics of fentanyl exemplify the increased potency and affordability noted in the market.
Why This Matters
The persistence of potent and affordable illicit drugs, as observed in Baltimore, highlights a significant divergence from the original goals of past drug control policies. This situation necessitates an understanding of the current market dynamics to comprehend ongoing challenges related to substance use and public health.